Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 70, 2015 - Issue 4
244
Views
3
CrossRef citations to date
0
Altmetric
Original Papers

Clinical features and outcome of typhoid fever and invasive non-typhoidal salmonellosis in a tertiary hospital in Belgium: analysis and review of the literature

, , , &

References

  • Cleary TG. Salmonella in Behrman: textbook of pediatrics. 16th edn. Philadelphia, PA: W.B. Saunders Company; 2000.
  • Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet. 2005;336:749–62.
  • Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. Typhoid fever. Lancet. 2014;S0140–6736(13):62708–7.
  • Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S.paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg. 2007;101:308–10.
  • Feasey NA, Archer BN, Heyderman RS, Sooka A, Dennis B, Gordon MA, et al. Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis. 2010;16(9):1448–51.
  • Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012;2(1):10401.
  • Waddington CS, Darton TC, Pollard AJ. The challenge of enteric fever. J Infect. 2014;68(Sup.1):S38–S50.
  • Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346–53.
  • Crump JA, Ram PK, Gupta SK, Miller MA, Mintz ED. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype typhi infections in low and medium human development index countries, 1984–2005. Epidemiol Infect. 2008;136(4):436–48.
  • Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype typhi infections in the United States: antimicrobial resistance on the rise. JAMA. 2000;283(20):2668–73.
  • Ryan CA, Hargrett-Bean NT, Blake PA. Salmonella typhi infections in the United States, 1975–1984: increasing role of foreign travel. Rev Infect Dis. 1989;11(1):1–8.
  • Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med. 1998;158(6):633–8.
  • Health Protection Agency. Salmonella typhi and Salmonella paratyphilaboratory reports (cases only) 2009. Available from: https://www.gov.uk/government/collections/salmonella-guidance-data-and-analysis.
  • Health Protection Agency. Salmonella typhi and Salmonella paratyphilaboratory reports (cases only). 2007. Available from: https://www.gov.uk/government/collections/salmonella-guidance-data-and-analysis.
  • Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50(6):882–9.
  • Su LH, Chiu CH, Wu TL, Chu C, Chia JH, Kuo AJ, et al. Molecular epidemiology of Salmonella enterica serovar Enteritidis isolated in Taiwan. Microbiol Immunol. 2002;46(12):833–40.
  • Westrell T, Ciampa N, Boelaert F, Helwigh B, Korsgaard H, Chriel M, et al. Zoonotic infections in Europe in 2007: a summary of the EFSA-ECDC annual report. Euro Surveill. 2009;14(3):19100.
  • Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: an update on epidemiology, management, and prevention. Travel Med Infect Dis. 2011;9(6):263–77.
  • Weinberger M, Keller N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis. 2005;18(6):513–21.
  • Laupland KB, Schønheyder HC, Kennedy KJ, Lyytikainen O, Valiquette L, Galbraith J, et al. Salmonella enterica bacteraemia: a multi-national population-based cohort study. BMC Infect Dis. 2010;10:95.
  • Données de surveillance du Centre Nationale de Référence des Salmonella et Shigella. Rapport annuel de l'Institut Scientifique de santé public. 2003; Available from: www.iph.fgov.be.
  • Bottieau E, Clerinx J, Schrooten W, Van den Enden E, Wouters R, Van Esbroeck M, et al. Etiology and outcome of fever after a stay in the tropics. Arch Intern Med. 2006;166:1642–8.
  • Données de surveillance du Centre Nationale de Référence des Salmonella et Shigella. Rapport annuel de l'Institut Scientifique de santé public. 2010; Available from: www.iph.fgov.be.
  • World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever. Geneva: World Health Organization; 2003;. WHO/V&B/03.07.
  • Shan N, DuPont HL, Ramsey DJ. Global etiology of travelers ‘diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009;80:609–14.
  • Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002;347:1770–82.
  • Vinh H, Wain J, Vo TN, Cao NN, Mai TC, Bethell D, et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother. 1996;40:958–61.
  • Gentilini M, Caumes E, Danis M, Richard-Lenoble D, Bégué P, Touze JE, et al. Médecine tropicale: Salmonelloses. Vol. 6. Paris: Lavoisier; 2012; p. 582–9.
  • Gotuzzo E, Echevarria J, Carrillo C, Sanchez J, Grados P, Maquina C, et al. Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever. Antimicrob Agents Chemother. 1994;38:558–62.
  • White NJ, Dung NM, Vinh H, Bethell D, Hien IT. Fluoroquinolone antibiotics in children with multidrug resistant typhoid. Lancet. 1996;348:547.
  • Cao XT, Kneen R, Nguyen TA, Truong DL, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai pediatric center typhoid study group. Pediatr Infect Dis J. 1999;18:245–8.
  • Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother. 1999;43:1441–4.
  • Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother. 2000;44:1855–9.
  • Dutta P, Rasaily R, Saha MR, Mitra U, Bhattacharya SK, Bhattacharya MK, et al. Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrob Agents Chemother. 1993;37:1197–9.
  • Parry CM. The treatment of multidrug-resistant and nalidixic acid resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg. 2004;98:413–22.
  • Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, Wierzba T, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis. 2004;38:951–7.
  • Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhira R, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother. 1999;44:243–50.
  • Frenck RW Jr, Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis. 2000;31:1134–8.
  • Memon IA, Billoo AG, Memon HI. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children. South Med J. 1997;90:1204–7.
  • Vlieghe ER, Phe T, De Smet B, Veng CH, Kham C, Bertrand S, et al. Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. PLoS Negl Trop Dis. 2012;6(12):1933.
  • Van Basten JP, Stockenbrugger R. Typhoid perforation. A review of the literature since 1960. Trop Geogr Med. 1994;46:336–9.
  • Butler T, Islam A, Kabir I, Jones PK. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. Rev Infect Dis. 1991;13:85–90.
  • Diesfeld HJ, Krause G, Teichmann D. Médecine tropicale et des voyages. Paris: Editions Maloine; 2003; p. 113–6.
  • Kankwatira AM, Mwafulirwa GAK, Gordon MA. Non-typhoidal salmonella bacteraemiaean under-recognized feature of AIDS in African adults. Trop Doct. 2004;34(4):198–200.
  • Larsen IK, Gradel KO, Helms M, Hornstrup MK, Jurgens G, Mens H, et al. Non-typhoidal Salmonella and Campylobacter infections among HIV-positive patients in Denmark. Scand J Infect Dis. 2011;43(1):3–7.
  • Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL. Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS. 2002;16(12):1633–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.